AKSA:BISTAksa Akrilik Kimya Sanayii A.S. Analysis
Data as of 2026-06-18 - not real-time
TRY 12.22
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical momentum is firmly bullish, with the MACD line comfortably above its signal and a rising volume trend supporting the price advance. The RSI sits in the upper half of its range, indicating strong buying pressure without yet being overbought. The stock is trading above its 20‑day and 50‑day moving averages, reinforcing the upward trend. Price remains comfortably above the identified support level, while still leaving room to approach the next resistance zone. Recent earnings show solid profit margins and a healthy operating cash flow, suggesting that the fundamentals can sustain the price move.
On the valuation side, the price‑to‑earnings ratio sits in a low double‑digit band and the price‑to‑book multiple is modest, placing the stock in an undervalued bracket relative to its target price. The upside potential implied by analyst targets exceeds twenty percent, offering an attractive risk‑reward profile. However, the balance sheet carries a high debt load and the company is exposed to Turkish lira volatility, which tempers the enthusiasm. The sector’s cyclical nature adds a layer of demand sensitivity, especially in textile and industrial markets. Overall, the confluence of bullish technicals, reasonable valuation and growth prospects supports a positive outlook, albeit with caution on debt and currency fronts.
On the valuation side, the price‑to‑earnings ratio sits in a low double‑digit band and the price‑to‑book multiple is modest, placing the stock in an undervalued bracket relative to its target price. The upside potential implied by analyst targets exceeds twenty percent, offering an attractive risk‑reward profile. However, the balance sheet carries a high debt load and the company is exposed to Turkish lira volatility, which tempers the enthusiasm. The sector’s cyclical nature adds a layer of demand sensitivity, especially in textile and industrial markets. Overall, the confluence of bullish technicals, reasonable valuation and growth prospects supports a positive outlook, albeit with caution on debt and currency fronts.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover with increasing volume
- Price above short‑term moving averages
- Support level provides downside cushion
Medium Term
1–3 yearsNeutral
Model confidence: 8/10
Key Factors
- Undervalued valuation metrics relative to target price
- Strong operating cash flow supporting earnings sustainability
- Elevated debt level warrants monitoring
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Blend of growth and value characteristics
- Long‑run upside potential exceeds twenty percent
- Currency and regulatory risks balanced by solid market position
Key Metrics & Analysis
Financial Health
Revenue Growth18.60%
Profit Margin12.90%
P/E Ratio10.9
ROE13.52%
ROA2.85%
Debt/Equity83.74
P/B Ratio1.4
Op. Cash FlowTRY6.8B
Free Cash FlowTRY411.6M
Technical Analysis
TrendBullish
RSI65.2
SupportTRY 9.99
ResistanceTRY 12.79
MA 20TRY 11.01
MA 50TRY 10.80
MA 200TRY 10.78
MACDBullish
VolumeIncreasing
Fear & Greed Index91.11
Valuation
Target PriceTRY 15.10
Upside/Downside23.57%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.26
Volatility48.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.